Published in J Virol on April 01, 2004
Comprehensive analysis of endogenous bornavirus-like elements in eukaryote genomes. Philos Trans R Soc Lond B Biol Sci (2013) 0.98
No evidence for natural selection on endogenous borna-like nucleoprotein elements after the divergence of Old World and New World monkeys. PLoS One (2011) 0.90
Adaptation of Borna disease virus to new host species attributed to altered regulation of viral polymerase activity. J Virol (2007) 0.88
Non-retroviral fossils in vertebrate genomes. Viruses (2011) 0.87
Animal models of CNS viral disease: examples from borna disease virus models. Interdiscip Perspect Infect Dis (2010) 0.83
Interferon-gamma prevents death of bystander neurons during CD8 T cell responses in the brain. Am J Pathol (2009) 0.83
Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes. J Virol (2008) 0.78
Pathogenic potential of borna disease virus lacking the immunodominant CD8 T-cell epitope. J Virol (2007) 0.75
Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol (2001) 7.30
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature (1994) 3.87
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods (1997) 2.97
Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell (1991) 2.83
GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci (1994) 2.77
Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol (1995) 2.11
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Epidemiology of Borna disease virus. J Gen Virol (2000) 1.89
Tissue-specific control elements of the Thy-1 gene. EMBO J (1990) 1.69
Superinfection exclusion of alphaviruses in three mosquito cell lines persistently infected with Sindbis virus. J Virol (1997) 1.63
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
Borna disease--neuropathology and pathogenesis. Curr Top Microbiol Immunol (1995) 1.59
Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J Gen Virol (1986) 1.51
Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science (1991) 1.46
Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo. J Exp Med (1995) 1.44
Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J Virol (2003) 1.40
Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology. J Virol (1998) 1.35
The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol (2000) 1.34
BHK cells expressing Sindbis virus-induced homologous interference allow the translation of nonstructural genes of superinfecting virus. J Virol (1985) 1.33
Immunopathogenesis of Borna disease. Curr Top Microbiol Immunol (1995) 1.33
Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization. J Neuropathol Exp Neurol (1991) 1.30
Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J Virol (2003) 1.27
CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol (1998) 1.27
Immune-mediated brain atrophy. CD8+ T cells contribute to tissue destruction during borna disease. J Immunol (1994) 1.19
The immunopathogenesis of Borna disease virus infection. Front Biosci (2002) 1.17
Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med (1996) 1.17
Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy. Exp Neurol (1998) 1.17
Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol (2003) 1.16
Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells. J Virol (2001) 1.14
GFAP Transgenic Mice Methods (1996) 1.13
Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene. J Exp Med (1994) 1.13
Astrocytes and Schwann cells are virus-host cells in the nervous system of rats with Borna disease. J Neuropathol Exp Neurol (1989) 1.12
Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci (1999) 1.09
T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc Natl Acad Sci U S A (1999) 1.08
Sequence variability of Borna disease virus: resistance to superinfection may contribute to high genome stability in persistently infected cells. J Virol (2000) 1.04
Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J Virol (1991) 1.00
Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc Natl Acad Sci U S A (2003) 0.97
Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response. J Virol (1999) 0.94
Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retroviruses (1995) 0.94
Learning deficits in mice with persistent Borna disease virus infection of the CNS associated with elevated chemokine expression. Behav Brain Res (2001) 0.91
Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein. J Virol (2001) 0.89
Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia (1994) 0.84
Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice. Virology (1996) 0.82
LCMV and the central nervous system: uncovering basic principles of CNS physiology and virus-induced disease. Curr Top Microbiol Immunol (2002) 0.80
Immunization-induced inflammatory infiltration of the central nervous system in transgenic mice expressing a microbial antigen in astrocytes. J Neuroimmunol (1995) 0.78
Transient induction of the glial intermediate filament protein gene in Müller cells in the mouse retina. DNA Cell Biol (1995) 0.78
Glial fibrillary acidic protein immunoreactivity in human respiratory tract cartilages and pulmonary chondromatous hamartomas. Am J Pathol (1988) 0.78
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 7.52
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol (2008) 3.75
Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci (2010) 3.61
IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A (2011) 2.47
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A (2007) 2.33
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity (2012) 2.23
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A (2009) 2.04
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
Interferon-induced Mx proteins in antiviral host defense. Biochimie (2007) 2.00
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol (2007) 1.93
Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol (2010) 1.92
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Protective role of beta interferon in host defense against influenza A virus. J Virol (2006) 1.80
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Invest (2008) 1.74
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol (2009) 1.69
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci U S A (2007) 1.68
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc Natl Acad Sci U S A (2008) 1.64
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem (2005) 1.64
Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A (2005) 1.61
Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron (2012) 1.58
Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease. J Virol (2009) 1.57
Pronuclear injection for the production of transgenic mice. Nat Protoc (2007) 1.50
Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One (2011) 1.45
Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis (2008) 1.42
Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J Virol (2003) 1.40
Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol (2007) 1.38
Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One (2010) 1.37
The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J Immunol (2007) 1.33
Primary support cultures of hippocampal and substantia nigra neurons. Nat Protoc (2009) 1.33
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol (2009) 1.32
Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. J Gen Virol (2007) 1.29
Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J Virol (2003) 1.27
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol (2003) 1.24
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci U S A (2010) 1.24
Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. J Mol Med (Berl) (2008) 1.23
Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One (2009) 1.23
Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol (2009) 1.22
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease. J Biol Chem (2009) 1.21
Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Eur J Neurosci (2008) 1.21
beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem (2003) 1.19
Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18
Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol (2009) 1.18
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol (2010) 1.16
Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. Anal Biochem (2004) 1.15
Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog (2013) 1.15
Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.12
Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. J Mol Neurosci (2011) 1.12
Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. J Gen Virol (2012) 1.10
Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc Natl Acad Sci U S A (2011) 1.09
Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics (2010) 1.08
MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease. Exp Neurol (2011) 1.08
High-avidity human serum antibodies recognizing linear epitopes of Borna disease virus proteins. Biol Psychiatry (2002) 1.08
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain. Vaccine (2009) 1.06
The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol (2013) 1.06
Rat model of borna disease virus transmission: epidemiological implications. J Virol (2003) 1.06
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain (2007) 1.06
Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle (2007) 1.05
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiol Dis (2004) 1.02
Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice. J Mol Biol (2004) 1.01
Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO J (2003) 1.01
The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein. J Gen Virol (2004) 1.00
Why size matters - balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci (2013) 1.00
Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res (2004) 1.00
Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One (2012) 0.98
Avian bornaviruses are widely distributed in canary birds (Serinus canaria f. domestica). Vet Microbiol (2013) 0.98
Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One (2012) 0.97
Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol (2012) 0.97
IL-18 stimulates the proliferation and IFN-gamma release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species. J Immunol (2003) 0.97
Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. Curr Drug Targets (2004) 0.96
Glial cells under physiologic and pathologic conditions. Arch Neurol (2002) 0.96
Nyamiviridae: proposal for a new family in the order Mononegavirales. Arch Virol (2013) 0.96
Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci (2002) 0.96
Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics (2006) 0.95
Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio. Antioxid Redox Signal (2012) 0.95
Decoding the non-coding RNAs in Alzheimer's disease. Cell Mol Life Sci (2012) 0.95
Brief update on different roles of tau in neurodegeneration. IUBMB Life (2011) 0.94
CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol (2005) 0.94
Altered proteostasis in aging and heat shock response in C. elegans revealed by analysis of the global and de novo synthesized proteome. Cell Mol Life Sci (2014) 0.94
Tau aggregation and its interplay with amyloid-β. Acta Neuropathol (2014) 0.93
Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the central nervous systems of newborn-infected rats. J Virol (2009) 0.93
Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures. FEBS Lett (2008) 0.93
Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J Virol (2011) 0.93
Polymerase read-through at the first transcription termination site contributes to regulation of borna disease virus gene expression. J Virol (2008) 0.92
Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex. J Biol Chem (2004) 0.92
Visualizing viral dissemination in the mouse nervous system, using a green fluorescent protein-expressing Borna disease virus vector. J Virol (2010) 0.92
What have we learned from the IL28 receptor knockout mouse? J Interferon Cytokine Res (2010) 0.91
Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity. Alzheimers Res Ther (2011) 0.91
Possibilities for the prevention and treatment of cognitive impairment and dementia. Br J Psychiatry (2007) 0.91
A Borna disease virus vector for expression of foreign genes in neurons of rodents. J Virol (2007) 0.91
Serological evidence for Borna disease virus infection in humans, wild rodents and other vertebrates in Finland. J Clin Virol (2006) 0.91
Comparing navigation-based in vivo knee kinematics pre- and postoperatively between a cruciate-retaining and a cruciate-substituting implant. Int Orthop (2013) 0.91
PTL-1 regulates neuronal integrity and lifespan in C. elegans. J Cell Sci (2013) 0.90
Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies? Trends Mol Med (2002) 0.90